Is Nuwellis, Inc. (NUWE) a Buy, Sell, or Hold?
Nuwellis, Inc.
NASDAQ:NUWE
$3.12 USD
-$0.1 (-3.11%)
- Volume
- 386.52K
- Average Volume
- 92.54K
- Market Capitalization
- $1.14M
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $908.25
- Year Low
- $2.73
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.56
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Michael McCormick |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | NUWE |
| CUSIP | 67113Y801 |
| CIK | 0001506492 |
| Web | https://www.nuwellis.com |
| Phone | 952 345 4200 |
| Currency | USD |
| Employees | 38 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.09 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.56 |
| Quick Ratio | 1.09 |
| Cash Ratio | 0.56 |
Sales & Book Value
| Annual Sales | $8.27M |
| Price / Sales | 0.13 |
| Cash Flow | -194.08 |
| Price / Cash Flow | -0.10 |
| Price / Book | 0.06 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 2 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-25.39 |
| Trailing P/E Ratio | 0.00 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-17.52M |
| Net Margin | -214.90% |
| Pretax Margin | -214.86% |
| Return on Equity | -17015.80% |
| Return on Assets | -262.98% |
Financials Score
| AltmanZ Score | -64.72 |
| Piotroski Score | 3.00 |
| Working Capital | 2.1M |
| Total Assets | 7.17M |
| Ebit | -8.29M |
| Market Cap | 1.17M |
| Total Liabilities | 4.29M |
Poll Results
About Nuwellis, Inc. (NASDAQ:NUWE) Stock
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. ...
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
2026-07-07 08:00:00
MINNEAPOLIS, July 07, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its participation in the KidneyBee Summit 2026, taking place July 14-16, 2026, at Children's Hospital Colorado in Aurora, Colorado. As part of its participation, Nuwellis will engage with conference attendees to discuss the role of precise fluid management in pediatric patients with acute kidney injury, cardiorenal conditions, and fluid overload.
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)
2026-06-26 08:00:00
MINNEAPOLIS, June 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces the five-year anniversary of its support of the annual conference for the Pediatric Cardiac Critical Care Consortium (PC4 ), an alliance aiming to improve the quality of care to patients with critical pediatric and congenital cardiovascular disease. Over the past five years, Nuwellis has collaborated with leading pediatric cardiac critical care institutions to support clinician education, scientific exchange, and awareness of fluid management strategies in critically ill children. Through these efforts, Nuwellis has helped foster dialogue around the growing clinical importance of fluid balance and the role of extracorporeal ultrafiltration therapies in pediatric intensive care settings.
Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations
2026-06-25 08:30:00
MINNEAPOLIS, June 25, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces its expansion in Michigan with the installation of three Aquadex SmartFlow® systems at a leading pediatric healthcare provider. This represents Nuwellis' first pediatric program in the state of Michigan and further expands the Company's growing presence in pediatric critical care into a significant healthcare market.
2026-06-24 08:30:00
MINNEAPOLIS, June 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, reviews the year-to-date and outlines strategic priorities in a Letter to Shareholders from newly appointed CEO, Mike McCormick.
2026-06-18 08:30:00
MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, highlighted the clinical utility of its Aquadex SmartFlow® system at the 4th annual Critical Care Cardiology Education Summit (CCCES), hosted by the University of Minnesota. As part of the conference's skills-based curriculum, conference instructors conducted focused Aquadex training sessions that provided participants with practical experience using the Company's ultrafiltration technology.
Nuwellis Appoints Mike McCormick as Chief Executive Officer
2026-06-16 08:30:00
Transition to become effective June 30, 2026; current CEO John Erb to continue as Chairman of the Board Transition to become effective June 30, 2026; current CEO John Erb to continue as Chairman of the Board
2026-06-10 08:30:00
South Carolina healthcare provider also upgrades to latest Aquadex devices at its two locations that already use the technology South Carolina healthcare provider also upgrades to latest Aquadex devices at its two locations that already use the technology
Nuwellis Announces Closing of $6.0 Million Registered Public Offering
2026-06-08 21:46:00
MINNEAPOLIS , June 08, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announces the closing of a public offering of 1,903,338 shares of its common stock ("Common Stock"), pre-funded warrants to purchase 18,096,662 shares of Common Stock, in each case with accompanying Series C Warrants to purchase up to 60,000,000 shares of Common Stock and Series D Warrants to purchase up to 20,000,000 shares of Common Stock with gross proceeds of approximately $6.0 million.
Frequently Asked Questions
-
What is the current Nuwellis, Inc. (NUWE) stock price?
-
Nuwellis, Inc.(NASDAQ:NUWE) stock price is $3.12 in the last trading session. During the trading session, NUWE stock reached the peak price of $908.25 while $2.73 was the lowest point it dropped to. The percentage change in NUWE stock occurred in the recent session was --3.11% while the dollar amount for the price change in NUWE stock was -$-0.1.
-
NUWE's industry and sector of operation?
-
The NASDAQ listed NUWE is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of NUWE?
-
Leah McMullen | Director of Communications
Betsy Riemenschneider | Vice President of Sales
David Lerner | Chief Technology Officer
John L. Erb | CEO, President & Chairman
Michael Kendrick McCormick | President, Chief Executive Officer & Director -
How many employees does NUWE have?
-
Number of NUWE employees currently stands at 38. NUWE operates from 12988 Valley View Road, Eden Prairie, MN 55344, US.
-
Link for NUWE official website?
-
Official Website of NUWE is: https://www.nuwellis.com
-
How do I contact NUWE?
-
NUWE could be contacted at phone #952 345 4200 and can also be accessed through its website. NUWE operates from 12988 Valley View Road, Eden Prairie, MN 55344, US.
-
How many shares of NUWE are traded daily?
-
The average number of NUWE shares traded daily for last 3 months was 92.54K.
-
What is the market cap of NUWE currently?
-
The market value of NUWE currently stands at $1.14M with its latest stock price at $3.12